CC Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.33B

-2.23%

0.021

-81.11%

1.44B

+5.2%

0.159

+22.57%

1.64B

+1.78%

0.655

+12.94%

Estimates Revision

The market is revising Downward the revenue expectations for The Chemours Company (CC) for FY2025, with the revenue forecasts being adjusted by -1.6% over the past three months. During the same period, the stock price has changed by 4.08%.

Revenue Estimates for FY2025

Revise Downward

-1.6%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-18.09%

In Past 3 Month

Stock Price

Go Up

+4.08%

In Past 3 Month

7 Analyst Rating

Wall Street analysts forecast CC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CC is 16.86 USD with a low forecast of 14.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

2 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

14.00

Averages

16.86

High

20.00

Current: 0.000

Low

14.00

Averages

16.86

High

20.00

JPMorgan

Neutral

downgrade

$15 -> $13

2025-12-03

Reason

JPMorgan

Price Target

$15 -> $13

2025-12-03

downgrade

Neutral

Reason

JPMorgan lowered the firm's price target on Chemours to $13 from $15 and keeps a Neutral rating on the shares.

UBS

Joshua Spector

Buy

downgrade

$21 -> $18

2025-11-11

Reason

UBS

Joshua Spector

Price Target

$21 -> $18

2025-11-11

downgrade

Buy

Reason

UBS analyst Joshua Spector lowered the firm's price target on Chemours to $18 from $21 and keeps a Buy rating on the shares.

RBC Capital

Arun Viswanathan

Outperform

downgrade

$19 -> $17

2025-11-10

Reason

RBC Capital

Arun Viswanathan

Price Target

$19 -> $17

2025-11-10

downgrade

Outperform

Reason

RBC Capital analyst Arun Viswanathan lowered the firm's price target on Chemours to $17 from $19 and keeps an Outperform rating on the shares after its Q3 earnings miss. The stock saw a positive reaction to the quarter but remains down over 25% YTD as pricing pressure remains in TiO2, and operational upsets in Advanced Performance Materials are offsetting gains in Thermal & Specialized Solutions, the analyst tells investors in a research note.

Mizuho

John Roberts

Outperform

downgrade

$18 -> $14

2025-11-07

Reason

Mizuho

John Roberts

Price Target

$18 -> $14

2025-11-07

downgrade

Outperform

Reason

Mizuho analyst John Roberts lowered the firm's price target on Chemours to $14 from $18 and keeps an Outperform rating on the shares.

Mizuho

John Roberts

Outperform -> NULL

downgrade

$19 -> $18

2025-10-16

Reason

Mizuho

John Roberts

Price Target

$19 -> $18

2025-10-16

downgrade

Outperform -> NULL

Reason

Mizuho analyst John Roberts lowered the firm's price target on Chemours to $18 from $19 and keeps an Outperform rating on the shares. The firm says the TiO2 industry has bifurcated into essentially China versus western multi-national producers.

RBC Capital

Outperform

maintain

$15 -> $19

2025-10-14

Reason

RBC Capital

Price Target

$15 -> $19

2025-10-14

maintain

Outperform

Reason

RBC Capital raised the firm's price target on Chemours to $19 from $15 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results for Chemicals companies. Recent conversations with the industry's Investor Relations teams have generally indicated that demand has remained somewhat tepid through Q3, the analyst tells investors in a research note. Building and Construction activity has been somewhat muted, and while rate cuts could help, a weak job market remains a headwind to new home starts and existing turnover, RBC added. Demand for consumer durables also has yet to see a material recovery, the firm states.

Valuation Metrics

The current forward P/E ratio for Chemours Co (CC.N) is 8.57, compared to its 5-year average forward P/E of 9.28. For a more detailed relative valuation and DCF analysis to assess Chemours Co 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

9.28

Current PE

8.57

Overvalued PE

12.80

Undervalued PE

5.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

6.75

Current EV/EBITDA

6.69

Overvalued EV/EBITDA

7.78

Undervalued EV/EBITDA

5.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.65

Current PS

0.31

Overvalued PS

0.84

Undervalued PS

0.46

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CC News & Events

Events Timeline

No data

News

8.0

21:03 PMNASDAQ.COM

IBM and LXEO Options Show Significant Volume Surge

4.0

2025-12-22Fool

Alta Fundamental Advisers Acquires 800,000 Shares of Chemours Worth $12.67 Million

2.0

2025-12-05NASDAQ.COM

Positive Cross of the 200-Day Moving Average - CC

People Also Watch

Frequently Asked Questions

What is Chemours Co (CC) stock price today?

The current price of CC is 14.3 USD — it has increased 3.25 % in the last trading day.

What is Chemours Co (CC)'s business?

The Chemours Company provides industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The Company’s segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Opteon, Freon, Ti-Pure, Nafion, Teflon, Viton, and Krytox. The Company serves over 2,700 customers in approximately 110 countries.

What is the price predicton of CC Stock?

What is Chemours Co (CC)'s revenue for the last quarter?

Chemours Co revenue for the last quarter amounts to 1.50B USD, decreased -0.86 % YoY.

What is Chemours Co (CC)'s earnings per share (EPS) for the last quarter?

Chemours Co. EPS for the last quarter amounts to 0.40 USD, decreased -290.48 % YoY.

What changes have occurred in the market's expectations for Chemours Co (CC)'s fundamentals?

How many employees does Chemours Co (CC). have?

Chemours Co (CC) has 6000 emplpoyees as of January 09 2026.

What is Chemours Co (CC) market cap?

Today CC has the market capitalization of 2.08B USD.